Clinical trial
Safety and Efficacy of Topically Applied CTA018 in Plaque Psoriasis
NCT00384098 · OPKO Health, Inc., Industry · Completed
Key facts
| NCT number | NCT00384098 |
|---|---|
| Title | Safety and Efficacy of Topically Applied CTA018 in Plaque Psoriasis |
| Official title | A Randomized, Double-blind, Parallel-group, 4-arm, 12-week Study to Evaluate the Safety and Efficacy of Topically Applied CTA018 vs Vehicle for the Treatment of Adult Subjects With Chronic Plaque Psoriasis |
| Lead sponsor | OPKO Health, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Psoriasis |
| Intervention type | Drug |
| Interventions | CTA018 cream |
| Enrollment | 140 |
| Start date | Sep 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Oct 4, 2006 |
| Last update posted | Sep 29, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: